Q4 2025 Humana Inc Earnings Call Transcript
Key Points
- Humana Inc (HUM) reported a solid performance for 2025, with adjusted EPS of $17.14, exceeding initial guidance.
- The company experienced significant membership growth, adding approximately 1 million members, a 20% increase during the Annual Enrollment Period (AEP).
- Retention rates improved by over 500 basis points year over year, indicating strong customer loyalty.
- Over 70% of new sales were from competitors' switchers, with a high percentage in contracts with 4 Stars or better.
- Humana Inc (HUM) anticipates individual Medicare Advantage (MA) membership growth of approximately 25% for 2026, with new members expected to be accretive to the enterprise.
- The company faces a significant Stars headwind for 2026, with a net impact of approximately $3.5 billion, affecting margins.
- Individual MA margins are expected to be slightly below breakeven in 2026, primarily due to the Stars headwind.
- The advanced rate notice for Medicare Advantage came in below medical cost trend, creating uncertainty in funding.
- There is a need for continued adaptation to the funding environment to maintain a stable and compelling margin.
- The company has embedded a higher level of conservatism in its 2026 guidance due to the dynamic environment, indicating potential challenges ahead.
Good day and thank you for standing by. Welcome to the Humana fourth-quarter 2025 earnings conference call. (Operator Instructions)
Please be advised that today's conference is being recorded. I would now like to hand the conference over to your speaker today, Lisa Stoner, Vice President of Investor Relations. Please go ahead.
Thank you and good morning. I hope everyone had a chance to review our press release and prepared remarks, which are available on our website. We will begin this morning with brief remarks from Jim Rechtin, Humana's President and Chief Executive Officer; and Chief Financial Officer, Celeste Mellet.
Before we begin our discussion, I need to advise call participants of our cautionary statement. Certain of the matters discussed in this conference call are forward-looking and involve a number of risks and uncertainties. Actual results could differ materially. Investors are advised to read the detailed risk factors discussed in our latest Form 10-K, our other
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
